Videla Richardson Guillermo Agustín, Garcia Carolina Paola, Roisman Alejandro, Slavutsky Irma, Fernandez Espinosa Damián Darío, Romorini Leonardo, Miriuka Santiago Gabriel, Arakaki Naomi, Martinetto Horacio, Scassa María Elida, Sevlever Gustavo Emilio
Laboratorio de Investigación aplicada a Neurociencias (LIAN), Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia (FLENI), Escobar, Provincia de Buenos Aires, Argentina.
Laboratorio de Neuropatología, Departamento de Neuropatología y Biología Molecular, Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia (FLENI), Buenos Aires, Argentina.
Brain Pathol. 2016 Jan;26(1):43-61. doi: 10.1111/bpa.12263. Epub 2015 May 19.
Although BMP4-induced differentiation of glioma stem cells (GSCs) is well recognized, details of the cellular responses triggered by this morphogen are still poorly defined. In this study, we established several GSC-enriched cell lines (GSC-ECLs) from high-grade gliomas. The expansion of these cells as adherent monolayers, and not as floating neurospheres, enabled a thorough study of the phenotypic changes that occurred during their differentiation. Herein, we evaluated GSC-ECLs' behavior toward differentiating conditions by depriving them of growth factors and/or by adding BMP4 at different concentrations. After analyzing cellular morphology, proliferation and lineage marker expression, we determined that GSC-ECLs have distinct preferences in lineage choice, where some of them showed an astrocyte fate commitment and others a neuronal one. We found that this election seems to be dictated by the expression pattern of BMP signaling components present in each GSC-ECL. Additionally, treatment of GSC-ECLs with the BMP antagonist, Noggin, also led to evident phenotypic changes. Interestingly, under certain conditions, some GSC-ECLs adopted an unexpected smooth muscle-like phenotype. As a whole, our findings illustrate the wide differentiation potential of GSCs, highlighting their molecular complexity and paving a way to facilitate personalized differentiating therapies.
尽管骨形态发生蛋白4(BMP4)诱导的胶质瘤干细胞(GSCs)分化已得到广泛认可,但这种形态发生素引发的细胞反应细节仍不清楚。在本研究中,我们从高级别胶质瘤中建立了几种富含GSC的细胞系(GSC-ECLs)。这些细胞以贴壁单层的形式扩增,而不是以悬浮神经球的形式,这使得我们能够深入研究其分化过程中发生的表型变化。在此,我们通过剥夺生长因子和/或添加不同浓度的BMP4来评估GSC-ECLs在分化条件下的行为。在分析细胞形态、增殖和谱系标记物表达后,我们确定GSC-ECLs在谱系选择上有明显的偏好,其中一些表现出向星形胶质细胞命运的定向分化,而另一些则表现出向神经元命运的定向分化。我们发现这种选择似乎由每个GSC-ECL中存在的BMP信号成分的表达模式决定。此外,用BMP拮抗剂Noggin处理GSC-ECLs也导致了明显的表型变化。有趣的是,在某些条件下,一些GSC-ECLs呈现出意想不到的平滑肌样表型。总体而言,我们的研究结果说明了GSCs具有广泛的分化潜力,突出了它们的分子复杂性,并为促进个性化分化治疗铺平了道路。